IBD Acute Severe Flare Management (ACG 2020)
IBD Acute Severe Flare Management (ACG 2020): Acute Severe IBD Flare → Assess Severity (Truelove-Witts) → Initial Workup → Complications Present? → ⚠️ S...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Acute Severe IBD Flare
Known IBD with severe symptoms requiring hospitalization
- ●Action
Assess Severity (Truelove-Witts)
For UC - defines acute severe colitis
- ≥6 bloody stools/day PLUS ≥1 of:
- • HR >90 bpm
- • Temp >37.8°C
- • Hgb <10.5 g/dL
- • ESR >30 mm/hr
- Crohn's: use CDAI or Harvey-Bradshaw
- ●Action
Initial Workup
Rule out complications and infections
- Stool C. diff, culture, ova & parasites
- CMV PCR or tissue (if on immunosuppression)
- CBC, CMP, CRP, ESR, albumin
- AXR or CT if concern for toxic megacolon
- Flexible sigmoidoscopy (limited, avoid perforation)
- ◆Decision
Complications Present?
Toxic megacolon, perforation, obstruction, abscess
- ⚠Warning
⚠️ Surgical Consult
Immediate surgical evaluation needed
- Toxic megacolon (colon >6cm)
- Perforation/peritonitis
- Uncontrolled hemorrhage
- Abscess (Crohn's) - may need IR drainage
- ⚠Warning
Colectomy
Subtotal colectomy with end ileostomy
- For UC: curative option
- Later IPAA (J-pouch) consideration
- Better outcomes with planned surgery vs. emergency
- ●Action
IV Corticosteroids
First-line for acute severe UC/Crohn's flare
- Methylprednisolone 60mg IV daily
- OR Hydrocortisone 100mg IV q8h
- NPO or clear liquids initially
- VTE prophylaxis (LMWH)
- Avoid antidiarrheals/opioids
- ●Action
Supportive Care
Concurrent management
- IV fluids, correct electrolytes
- Transfuse if Hgb <7-8
- Nutrition (enteral > TPN if possible)
- VTE prophylaxis essential
- Daily clinical and AXR assessment
- ◆Decision
Day 3 Assessment
Evaluate response to IV steroids
- Oxford criteria: stool frequency + CRP
- >8 stools/day OR 3-8 stools + CRP >45 = likely steroid failure
- ●Action
Steroid Response
Improving by day 3-5
- Continue IV steroids until stable
- Transition to PO prednisone
- Start/optimize maintenance therapy
- Taper steroids over 6-8 weeks
- ✓Outcome
Clinical Remission
Optimize maintenance therapy, close outpatient follow-up
- ✓Outcome
Maintenance Therapy
Infliximab, adalimumab, vedolizumab, ustekinumab, tofacitinib per disease
- ⚠Warning
Steroid-Refractory (No response by day 3-5)
Rescue therapy needed
- Infliximab 5-10 mg/kg IV (preferred)
- OR Cyclosporine 2-4 mg/kg/day IV
- OR Vedolizumab (slower onset)
- Check CMV, C. diff again
- Continue surgical evaluation
- ◆Decision
Response to Rescue Therapy?
Assess by day 5-7 of rescue therapy
Guideline Source
ACG Clinical Guidelines: Ulcerative Colitis in Adults (2019) & Crohn's Disease (2018)
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Primarily addresses acute severe UC (Truelove-Witts criteria)
- Crohn's flares may have different triggers (abscess, stricture)
- Biologic choice evolving rapidly
- CMV reactivation testing important in refractory cases
- Surgical timing requires multidisciplinary input
Applicable Regions
EU: ECCO guidelines are similar
US: ACG guidelines current standard
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Glasgow-Blatchford Bleeding Score
Upper GI bleed risk stratification and need for intervention
Compare
AttendMe.ai vs UpToDate
See how this pathway workflow compares against UpToDate.
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Related Resources
Frequently Asked Questions
What is the IBD Acute Severe Flare Management (ACG 2020)?
The IBD Acute Severe Flare Management (ACG 2020) is a emergency clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on ACG Clinical Guidelines: Ulcerative Colitis in Adults (2019) & Crohn's Disease (2018).
What guideline is the IBD Acute Severe Flare Management (ACG 2020) based on?
This algorithm is based on ACG Clinical Guidelines: Ulcerative Colitis in Adults (2019) & Crohn's Disease (2018) (DOI: 10.14309/ajg.0000000000000152).
What are the limitations of the IBD Acute Severe Flare Management (ACG 2020)?
Known limitations include: Primarily addresses acute severe UC (Truelove-Witts criteria); Crohn's flares may have different triggers (abscess, stricture); Biologic choice evolving rapidly; CMV reactivation testing important in refractory cases; Surgical timing requires multidisciplinary input. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the IBD Acute Severe Flare Management (ACG 2020) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free